The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population

被引:68
作者
Osorio, A
Rodríguez-López, R
Díez, O
de la Hoya, M
Martínez, JI
Vega, A
Esteban-Cardeñosa, E
Alonso, C
Caldés, T
Benítez, J
机构
[1] Spanish Natl Canc Ctr, Dept Human Genet, Madrid 28029, Spain
[2] Fac Med, Dept Chem & Mol Biol, Valladolid, Spain
[3] Conxo Hosp, Dept Mol Med, Santiago De Compostela, Spain
[4] FVIB, Inst Invest Citol, Valencia, Spain
[5] San Carlos Univ Hosp, Mol Oncol Lab, Madrid, Spain
[6] Sant Pau Hosp, Serv Genet, Barcelona, Spain
[7] Sant Pau Hosp, Serv Oncol, Barcelona, Spain
关键词
CHEK2; low-penetrance variant; familial breast cancer; Spanish population;
D O I
10.1002/ijc.11414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Searching for low-penetrance genes involved in breast cancer susceptibility has been a field of interest in the last few years. Recently, the CHEK 2 gene, involved in DNA damage and replication checkpoints, has been pointed out as a good candidate; moreover, a specific variant in this gene, 1100delC, has been found to increase breast cancer susceptibility among familial breast cancer cases not attributable to mutations in BRCA1 or BRCA2 genes. In our present study, we evaluated the role of the 1100delC variant as a susceptibility allele in breast cancer in the Spanish population. However, our results suggest that this variant is absent or very infrequent in our population, making its screening irrelevant from the practical point of view. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:54 / 56
页数:3
相关论文
共 18 条
  • [1] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
    Bell, DW
    Varley, JM
    Szydlo, TE
    Kang, DH
    Wahrer, DCR
    Shannon, KE
    Lubratovich, M
    Verselis, SJ
    Isselbacher, KJ
    Fraumeni, JF
    Birch, JM
    Li, FP
    Garber, JE
    Haber, DA
    [J]. SCIENCE, 1999, 286 (5449) : 2528 - 2531
  • [2] BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families
    Campos, B
    Díez, O
    Domènech, M
    Baena, M
    Pericay, C
    Balmaña, J
    del Río, E
    Sanz, J
    Alonso, C
    Baiget, M
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (12) : 1699 - 1703
  • [3] de la Hoya M, 2001, INT J CANCER, V91, P137, DOI 10.1002/1097-0215(20010101)91:1<137::AID-IJC1020>3.0.CO
  • [4] 2-R
  • [5] Mutations in CHEK2 associated with prostate cancer risk
    Dong, XY
    Wang, L
    Taniguchi, K
    Wang, XS
    Cunningham, JM
    McDonnell, SK
    Qian, CP
    Marks, AF
    Slager, SL
    Peterson, BJ
    Smith, BI
    Cheville, JC
    Blute, ML
    Jacobsen, SJ
    Schaid, DJ
    Tindall, DJ
    Thibodeau, SN
    Liu, WG
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) : 270 - 280
  • [6] How many more breast cancer predisposition genes are there?
    Douglas F Easton
    [J]. Breast Cancer Research, 1 (1)
  • [7] hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
    Lee, JS
    Collins, KM
    Brown, AL
    Lee, CH
    Chung, JH
    [J]. NATURE, 2000, 404 (6774) : 201 - 204
  • [8] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
    Meijers-Heijboer, H
    van den Ouweland, A
    Klijn, J
    Wasielewski, M
    de Snoo, A
    Oldenburg, R
    Hollestelle, A
    Houben, M
    Crepin, E
    van Veghel-Plandsoen, M
    Elstrodt, F
    van Duijn, C
    Bartels, C
    Meijers, C
    Schutte, M
    McGuffog, L
    Thompson, D
    Easton, DF
    Sodha, N
    Seal, S
    Barfoot, R
    Mangion, J
    Chang-Claude, J
    Eccles, D
    Eeles, R
    Evans, DG
    Houlston, R
    Murday, V
    Narod, S
    Peretz, T
    Peto, J
    Phelan, C
    Zhang, HX
    Szabo, C
    Devilee, P
    Goldgar, D
    Futreal, PA
    Nathanson, KL
    Weber, BL
    Rahman, N
    Stratton, MR
    [J]. NATURE GENETICS, 2002, 31 (01) : 55 - 59
  • [9] OFFIT K, 2003, BMC MED GENET, V15, P1
  • [10] Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
    Osorio, A
    Barroso, A
    Martínez, B
    Cebrián, A
    San Román, JM
    Lobo, F
    Robledo, M
    Benítez, J
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (07) : 1266 - 1270